Which interventions offer best value for money in primary prevention of cardiovascular disease?

Thumbnail Image
File version

Version of Record (VoR)

Cobiac, LJ
Magnus, A
Lim, S
Barendregt, JJ
Carter, R
Vos, T
Griffith University Author(s)
Primary Supervisor
Other Supervisors
File type(s)

Background: Despite many decades of declining mortality rates in the Western world, cardiovascular disease remains the leading cause of death worldwide. In this research we evaluate the optimal mix of lifestyle, pharmaceutical and population-wide interventions for primary prevention of cardiovascular disease. Methods and Findings: In a discrete time Markov model we simulate the ischaemic heart disease and stroke outcomes and cost impacts of intervention over the lifetime of all Australian men and women, aged 35 to 84 years, who have never experienced a heart disease or stroke event. Best value for money is achieved by mandating moderate limits on salt in the manufacture of bread, margarine and cereal. A combination of diuretic, calcium channel blocker, ACE inhibitor and low-cost statin, for everyone with at least 5% five-year risk of cardiovascular disease, is also cost-effective, but lifestyle interventions aiming to change risky dietary and exercise behaviours are extremely poor value for money and have little population health benefit. Conclusions: There is huge potential for improving efficiency in cardiovascular disease prevention in Australia. A tougher approach from Government to mandating limits on salt in processed foods and reducing excessive statin prices, and a shift away from lifestyle counselling to more efficient absolute risk-based prescription of preventive drugs, could cut health care costs while improving population health. © 2012 Cobiac et al.

Journal Title

PLoS One

Conference Title
Book Title




Thesis Type
Degree Program
Publisher link
Patent number
Grant identifier(s)
Rights Statement
Rights Statement

© 2012 Cobiac et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Item Access Status
Access the data
Related item(s)
Persistent link to this record

Cobiac, LJ; Magnus, A; Lim, S; Barendregt, JJ; Carter, R; Vos, T, Which interventions offer best value for money in primary prevention of cardiovascular disease?, PLoS One, 2012, 7 (7), pp. e41842